Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Patient Reported Outcome Measures × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neoplasms 4 Radiation Injuries 2 Multiple Myeloma 2 Multiple Chronic Conditions 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Esophageal Neoplasms 2 Cognitive Dysfunction 2 Brain Neoplasms 2 Substance-Related Disorders 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Pain 1 Neoplasms, Second Primary 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Leukemia 1 Kidney Neoplasms 1 Hyperthermia 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Financial Stress 1 Fatigue 1 Cystic Fibrosis 1 Congenital Abnormalities 1 Catheter-Related Infections 1

Interventions

Diathermy 17 Radiotherapy 10 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Conization 2 spartalizumab 1 anlotinib 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06452485 2025-10-06

RT-HYPE

Amsterdam UMC, location VUmc

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡